Miller Lisa K sold 14,663 shares of LifeStance Health Group, Inc. at $14.68 for −$215k on Nov 11, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Operating Officer
Chief Operating Officer
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$215,252.84Shares × reported price
Shares traded
14,663Common Stock
Price per share
$14.68Reported price. Read footnotes for ranges.
% of reported position traded
5.5%This security and ownership context
Holdings after
251,904Direct
Trade date
Nov 11, 2026Sell
Filed
Nov 12, 2026, 5:00 PM ET1-day reporting delay
Accession
0001193125-26-458678Code S · Transaction 399317
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 266,567 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 10, 2026Tax withholding14,722$14.56−$214,352.32Trade 399316
2 transaction rows in this filing. Joint filers share the same rows.

LFST price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
LFST · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −4.7%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on November 10, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale. F2: Represents shares sold pursuant to a plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) that was adopted on May 7, 2026.